Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Inspira Technologies Oxy BHN ( (IINN) ) just unveiled an announcement.
On January 27, 2025, Inspira Technologies announced enhancements to its INSPIRA ART100 system, aimed at improving medical team efficiency and support. These features include advanced software for real-time monitoring and integration with hospital procedures, enhancing user experience during critical care. This development reinforces Inspira’s leadership in extracorporeal life support technology, potentially impacting the market by offering alternatives to traditional mechanical ventilation.
More about Inspira Technologies Oxy BHN
Inspira Technologies OXY B.H.N. Ltd. is a leading company in the innovative medical technology sector, focusing on life support and respiratory treatment solutions. It is developing Augmented Respiration Technology (INSPIRA ART), targeting to revolutionize the $19 billion mechanical ventilation market. The company aims to provide alternatives for managing acute respiratory failure in intensive care units, with products like the INSPIRA ART100, which has received FDA clearance and Israeli certification.
YTD Price Performance: -4.76%
Average Trading Volume: 694,846
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $18.36M
Learn more about IINN stock on TipRanks’ Stock Analysis page.
